{
  "success": true,
  "pagesUsed": [
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    21,
    22,
    23,
    24,
    25,
    27,
    28,
    29,
    30,
    31,
    32,
    33,
    34,
    35,
    36,
    37,
    38,
    39,
    40,
    41,
    42,
    43,
    44,
    45,
    46,
    48,
    49
  ],
  "modelUsed": "gemini-3-flash-preview",
  "interventions": {
    "studyInterventions": [
      {
        "id": "int_1",
        "name": "Daratumumab",
        "type": {
          "id": "766a13ea-d7e3-4cde-bf49-8e7b6a014e95",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "role": {
          "id": "8664f2e8-d4fd-416f-9661-48b4bdf207b7",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Human IgG1κ monoclonal antibody that binds to CD38.",
        "productIds": [
          "prod_1"
        ],
        "administrationIds": [
          "admin_1"
        ]
      },
      {
        "id": "int_2",
        "name": "Lenalidomide",
        "type": {
          "id": "02e08a4a-bf57-46ae-9d5a-fc451a44313f",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "role": {
          "id": "0653e1f5-5314-4be8-a5d1-7e4df6131cc5",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Standard of care therapy for multiple myeloma administered in both Arm A and Arm B.",
        "productIds": [
          "prod_2"
        ],
        "administrationIds": [
          "admin_2"
        ]
      },
      {
        "id": "int_3",
        "name": "Dexamethasone",
        "type": {
          "id": "4571427d-0e8f-433f-b425-d83f1ed73187",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "role": {
          "id": "5ae17e51-a7ac-4da0-9ee4-18eaa5e4bceb",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Corticosteroid administered in both Arm A and Arm B; also used as pre-dose medication.",
        "productIds": [
          "prod_3"
        ],
        "administrationIds": [
          "admin_3"
        ]
      },
      {
        "id": "int_4",
        "name": "Acetaminophen/paracetamol",
        "type": {
          "id": "785f29c2-f835-4a12-8699-956bdc8ff97a",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "6fc12e2b-2ec8-4b6f-955c-d1527e87dfdb",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Required pre-dose medication to prevent infusion-related reactions.",
        "productIds": [
          "prod_4"
        ],
        "administrationIds": [
          "admin_4"
        ]
      },
      {
        "id": "int_5",
        "name": "Antihistamine",
        "type": {
          "id": "a2fa3ff2-897c-42cc-b132-41d903d5029a",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "d29bcac6-72d8-4ede-aaea-3af77ed82016",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Required pre-dose medication (e.g., diphenhydramine) to prevent infusion-related reactions."
      },
      {
        "id": "int_6",
        "name": "Aspirin",
        "type": {
          "id": "b48389cb-e67e-4b3b-a81f-09aa5c919cc9",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "1c7f62d6-ea95-48b7-a643-b7a82d99fa1c",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Recommended prophylaxis for deep vein thrombosis and pulmonary embolism."
      },
      {
        "id": "int_7",
        "name": "Low molecular weight heparin",
        "type": {
          "id": "31025e4d-43d8-4076-aff6-56712d7a41dc",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "26f869af-830b-421f-94db-b18985ace8d3",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Recommended prophylaxis for venous thromboembolism in high-risk subjects."
      },
      {
        "id": "int_8",
        "name": "Clarithromycin",
        "type": {
          "id": "3848cd06-c84d-4daa-aa89-a858f72b4fc3",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "2e91b69d-d0b6-4239-bc13-39a794926f50",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Prohibited therapy due to potential anti-multiple myeloma effects."
      }
    ],
    "administrableProducts": [
      {
        "id": "prod_1",
        "name": "Daratumumab IV",
        "administrableDoseForm": {
          "id": "11416d97-5bdf-4d8a-8ac2-fb635d58abe7",
          "code": "C42986",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Solution",
          "standardCode": {
            "id": "b503dd9a-20c9-4574-bb55-70274996df48",
            "code": "C42986",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Solution",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "dd5a0a10-6ddd-47b4-9279-cb59d7571ed9",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "20 mg/mL",
        "substanceIds": [
          "sub_1"
        ],
        "manufacturer": "Janssen Pharmaceutica NV"
      },
      {
        "id": "prod_2",
        "name": "Daratumumab SC",
        "administrableDoseForm": {
          "id": "de85838f-4737-47f9-a1b3-ff5aa9970bab",
          "code": "C42945",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Injection",
          "standardCode": {
            "id": "af1132d9-db71-4fe7-80fd-21360f37ddd9",
            "code": "C42945",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Injection",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "c0be0171-4098-41ad-aee6-8d9a048a7b24",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "1800 mg",
        "substanceIds": [
          "sub_2"
        ],
        "manufacturer": "Janssen Pharmaceutica NV"
      },
      {
        "id": "prod_3",
        "name": "Lenalidomide",
        "administrableDoseForm": {
          "id": "18007102-ee9d-417f-87b9-3b9cfbf0376a",
          "code": "C25158",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Capsule",
          "standardCode": {
            "id": "7172454b-9826-414b-b9a3-4140036e2e7c",
            "code": "C25158",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Capsule",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "f0cc197f-a3c6-4de9-9fad-3f4f2a7f8d01",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "25 mg, 15 mg, 10 mg, 5 mg",
        "substanceIds": [
          "sub_3"
        ],
        "manufacturer": "Not specified"
      },
      {
        "id": "prod_4",
        "name": "Dexamethasone",
        "administrableDoseForm": {
          "id": "21eea359-7131-4d32-b37e-1ccd7ac66ef6",
          "code": "C42998",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Tablet",
          "standardCode": {
            "id": "14a9c329-9a8d-49dc-a1a7-f56b92fc36bb",
            "code": "C42998",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Tablet",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "d786dd31-909a-4120-a16b-19a5c5149cf8",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "40 mg, 20 mg",
        "substanceIds": [
          "sub_4"
        ],
        "manufacturer": "Not specified"
      }
    ],
    "administrations": [
      {
        "id": "admin_1",
        "name": "Daratumumab IV Regimen",
        "instanceType": "Administration",
        "dose": "16 mg/kg",
        "doseFrequency": "Weekly (C1-2), Every 2 weeks (C3-6), Every 4 weeks (C7+)",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "Until disease progression or unacceptable toxicity"
      },
      {
        "id": "admin_2",
        "name": "Daratumumab SC Regimen",
        "instanceType": "Administration",
        "dose": "1800 mg",
        "doseFrequency": "Weekly (C1-2), Every 2 weeks (C3-6), Every 4 weeks (C7+)",
        "route": {
          "code": "Subcutaneous",
          "codeSystem": "USDM",
          "decode": "Subcutaneous"
        },
        "duration": "Until disease progression or unacceptable toxicity"
      },
      {
        "id": "admin_3",
        "name": "Lenalidomide Regimen",
        "instanceType": "Administration",
        "dose": "25 mg",
        "doseFrequency": "Once daily on Days 1-21 of each 28-day cycle",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "Until disease progression or unacceptable toxicity"
      },
      {
        "id": "admin_4",
        "name": "Dexamethasone Regimen",
        "instanceType": "Administration",
        "dose": "40 mg",
        "doseFrequency": "Weekly",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "Until disease progression or unacceptable toxicity"
      }
    ],
    "substances": [
      {
        "id": "sub_1",
        "name": "Daratumumab",
        "instanceType": "Substance",
        "description": "Human IgG1κ monoclonal antibody"
      },
      {
        "id": "sub_2",
        "name": "rHuPH20",
        "instanceType": "Substance",
        "description": "Recombinant human hyaluronidase PH20 (used in SC formulation)"
      },
      {
        "id": "sub_3",
        "name": "Lenalidomide",
        "instanceType": "Substance",
        "description": "Immunomodulatory imide drug (IMiD)"
      },
      {
        "id": "sub_4",
        "name": "Dexamethasone",
        "instanceType": "Substance",
        "description": "Glucocorticoid"
      }
    ],
    "medicalDevices": [
      {
        "id": "dev_1",
        "name": "Electronic device (ePRO)",
        "instanceType": "MedicalDevice",
        "manufacturer": "Not specified"
      }
    ],
    "summary": {
      "interventionCount": 8,
      "productCount": 4,
      "deviceCount": 1
    }
  },
  "rawResponse": {
    "interventions": [
      {
        "name": "Daratumumab",
        "role": "Investigational Product",
        "description": "Human IgG1κ monoclonal antibody that binds to CD38."
      },
      {
        "name": "Lenalidomide",
        "role": "Background Therapy",
        "description": "Standard of care therapy for multiple myeloma administered in both Arm A and Arm B."
      },
      {
        "name": "Dexamethasone",
        "role": "Background Therapy",
        "description": "Corticosteroid administered in both Arm A and Arm B; also used as pre-dose medication."
      },
      {
        "name": "Acetaminophen/paracetamol",
        "role": "Concomitant Medication",
        "description": "Required pre-dose medication to prevent infusion-related reactions."
      },
      {
        "name": "Antihistamine",
        "role": "Concomitant Medication",
        "description": "Required pre-dose medication (e.g., diphenhydramine) to prevent infusion-related reactions."
      },
      {
        "name": "Aspirin",
        "role": "Concomitant Medication",
        "description": "Recommended prophylaxis for deep vein thrombosis and pulmonary embolism."
      },
      {
        "name": "Low molecular weight heparin",
        "role": "Concomitant Medication",
        "description": "Recommended prophylaxis for venous thromboembolism in high-risk subjects."
      },
      {
        "name": "Clarithromycin",
        "role": "Concomitant Medication",
        "description": "Prohibited therapy due to potential anti-multiple myeloma effects."
      }
    ],
    "products": [
      {
        "name": "Daratumumab IV",
        "doseForm": "Solution",
        "strength": "20 mg/mL",
        "manufacturer": "Janssen Pharmaceutica NV"
      },
      {
        "name": "Daratumumab SC",
        "doseForm": "Injection",
        "strength": "1800 mg",
        "manufacturer": "Janssen Pharmaceutica NV"
      },
      {
        "name": "Lenalidomide",
        "doseForm": "Capsule",
        "strength": "25 mg, 15 mg, 10 mg, 5 mg",
        "manufacturer": "Not specified"
      },
      {
        "name": "Dexamethasone",
        "doseForm": "Tablet",
        "strength": "40 mg, 20 mg",
        "manufacturer": "Not specified"
      }
    ],
    "substances": [
      {
        "name": "Daratumumab",
        "description": "Human IgG1κ monoclonal antibody"
      },
      {
        "name": "rHuPH20",
        "description": "Recombinant human hyaluronidase PH20 (used in SC formulation)"
      },
      {
        "name": "Lenalidomide",
        "description": "Immunomodulatory imide drug (IMiD)"
      },
      {
        "name": "Dexamethasone",
        "description": "Glucocorticoid"
      }
    ],
    "administrations": [
      {
        "name": "Daratumumab IV Regimen",
        "dose": "16 mg/kg",
        "frequency": "Weekly (C1-2), Every 2 weeks (C3-6), Every 4 weeks (C7+)",
        "route": "Intravenous",
        "duration": "Until disease progression or unacceptable toxicity"
      },
      {
        "name": "Daratumumab SC Regimen",
        "dose": "1800 mg",
        "frequency": "Weekly (C1-2), Every 2 weeks (C3-6), Every 4 weeks (C7+)",
        "route": "Subcutaneous",
        "duration": "Until disease progression or unacceptable toxicity"
      },
      {
        "name": "Lenalidomide Regimen",
        "dose": "25 mg",
        "frequency": "Once daily on Days 1-21 of each 28-day cycle",
        "route": "Oral",
        "duration": "Until disease progression or unacceptable toxicity"
      },
      {
        "name": "Dexamethasone Regimen",
        "dose": "40 mg",
        "frequency": "Weekly",
        "route": "Oral or Intravenous",
        "duration": "Until disease progression or unacceptable toxicity"
      }
    ],
    "devices": [
      {
        "name": "Electronic device (ePRO)",
        "manufacturer": "Not specified",
        "purpose": "Collection of Patient Reported Outcomes"
      }
    ]
  }
}